RO103682A2 - Isolation method of human ceruloplasmin - Google Patents

Isolation method of human ceruloplasmin

Info

Publication number
RO103682A2
RO103682A2 RO13784989A RO13784989A RO103682A2 RO 103682 A2 RO103682 A2 RO 103682A2 RO 13784989 A RO13784989 A RO 13784989A RO 13784989 A RO13784989 A RO 13784989A RO 103682 A2 RO103682 A2 RO 103682A2
Authority
RO
Romania
Prior art keywords
isolation method
human ceruloplasmin
human
ceruloplasmin
imcuso4
Prior art date
Application number
RO13784989A
Other languages
Romanian (ro)
Other versions
RO103682B1 (en
Inventor
Aurel Ionita
Constantina Ionita
Emil Ionita
Original Assignee
Cantacuzino Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantacuzino Inst filed Critical Cantacuzino Inst
Priority to RO137849A priority Critical patent/RO103682B1/en
Publication of RO103682A2 publication Critical patent/RO103682A2/en
Publication of RO103682B1 publication Critical patent/RO103682B1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Sera or human plasma is treated with a soln. of IMCuSO4 (100:0.4) and maintained at 68 deg.C for 30 mins. centrifuged, chromatographed over DEAE-sepharose Cl-68 using 0.02M Napyrophosphate and acetic acid, at pH 7.5 and the Cibacron-Blue F3GA-Biogel A5m with 0.05M TFS at pH7.
RO137849A 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin RO103682B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO137849A RO103682B1 (en) 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO137849A RO103682B1 (en) 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin

Publications (2)

Publication Number Publication Date
RO103682A2 true RO103682A2 (en) 1991-12-09
RO103682B1 RO103682B1 (en) 1992-03-26

Family

ID=20123823

Family Applications (1)

Application Number Title Priority Date Filing Date
RO137849A RO103682B1 (en) 1989-01-20 1989-01-20 Isolation method of human ceruloplasmin

Country Status (1)

Country Link
RO (1) RO103682B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1232251A4 (en) * 1999-11-13 2004-09-01 Bayer Healthcare Llc Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1232251A4 (en) * 1999-11-13 2004-09-01 Bayer Healthcare Llc Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US7871608B2 (en) 1999-11-13 2011-01-18 Talecris Biotherapeutics, Inc. Reversibly inactivated acidified plasmin
EP1232251B2 (en) † 1999-11-13 2017-05-17 Grifols Therapeutics Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US9879246B2 (en) 1999-11-13 2018-01-30 Grifols Therapeutics Inc. Reversibly inactivated acidified plasmin composition

Also Published As

Publication number Publication date
RO103682B1 (en) 1992-03-26

Similar Documents

Publication Publication Date Title
EP0875563A3 (en) Improved methods for processing activated protein C
AU601961B2 (en) Method for reducing the intraocular pressure of mammals
AU2710188A (en) Enzymatic treatment of wool
AU6518890A (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
AU7527987A (en) A method for the prevention of fusarium diseases and microorganisms used for the same
WO1990012879A3 (en) Expression of human apolipoproteins ai-milano in yeast
AU3198589A (en) A method for treatment of hypercortisolemic, depressed patients
AU5317390A (en) Concentrated aqueous solution of glutaraldehyde and 1,2-benzisothiazolin-3-one
AU561222B2 (en) Process for the pasteurization of human plasma
RO103682A2 (en) Isolation method of human ceruloplasmin
AU2607184A (en) Process of treating an aqueous condensate
WO1997012963A3 (en) A paf-acetylhydrolase and use in therapy
AU2659088A (en) Method for the treatment of anxiety
AU617187B2 (en) Treatment of aqueous dispersions
AU581558B2 (en) Gas treatment process
AU7334187A (en) Method of curve approximation
OA08402A (en) Method for the treatment of natural rubber field latex.
IL115826A0 (en) Use of erythropoietin in the treatment of rheumatoid arthritis
AU578079B2 (en) A method for the treatment of glaucoma
EP0333020A3 (en) Process for the preparation of substituted pyridines
AU4201289A (en) Method for the isolation of dna
GR3006794T3 (en)
AU8013587A (en) A method and composition for the treatment of bathtubs
AU7438900A (en) Recombinant antigen of taenia solium metacestodes
AU5476598A (en) Method of obtaining haemin from slaughter blood